Use of algorithms for predicting survival of a patient treated with extracorporeal membrane oxygenation

Extra-corporeal membrane oxygenation (ECMO) has since been increasingly deployed, to become integral to the therapeutic arsenal of the intensive care unit for patients suffering from cardiac and/or respiratory insufficiency. The inventors endeavored to explore the potential of hemolysis index (HI) monitoring during ECMO in a retrospective study including 115 patients for which EMCO was deployed. In particular, the inventors the inventors used machine-learning algorithms to build a decisional tree including the HI level as a predictive factor for patients under ECMO. Thus the present invention relates to use of algorithms for predicting survival of a patient having extracorporeal membrane oxygenation.

Keywords: EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO), Patient survival, IA based algorythms,
Patent Application number: EP20 315 122.0 on 06/04/2020

Reference:

BIO20088-D1

Business Developper
contact
Pierre MAZOT
Pierre MAZOT
Business Developer
Patent filling date: 2020-04-06

You might also be interested in